BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Inflammatory gene profiling of Ewing sarcoma family of tumors (set B)

Dataset: Inflammatory gene profiling of Ewing sarcoma family of tumors (set B)

Purpose: Unlike in most adult-onset cancers, an association between typical paediatric neoplasms and inflammatory triggers is rare. We...

Registered by ArrayExpress Uploader
View Dataset

Purpose: Unlike in most adult-onset cancers, an association between typical paediatric neoplasms and inflammatory triggers is rare. We studied whether immune system related genes are activated and have prognostic significance in Ewing sarcoma family of tumours (ESFT). Experimental design: Data-analysis was performed on gene expression profiles of 44 ESFT patient, 11 ESFT cell line, and 18 normal muscle tissue samples. 238 inflammation related genes were selected based on literature and a macrophage gene expression signature was derived from SymAtlas. Differential expression of the genes was analysed by t-test and survival analysis was performed according to gene expression. Results: Inflammatory genes are activated in ESFT patient samples, as 38 of 238 (16%) inflammatory genes were significantly upregulated (p<0.001) when compared to ESFT cell lines. This inflammatory gene activation was characterized by significant enrichment of macrophage related gene expression with 58 of 299 (19%) of these genes being upregulated (p<0.001). By combining expression data from ESFT patients, cell lines and muscle tissue samples we were able to identify a total of 32 presumptive inflammatory genes that characterize and distinguish tumour site in vivo from surrounding normal tissues. High expression of C5 correlated with better event free (p=0.01) and overall survival (p=0.004) in dose dependent manner. C5 and its receptor C5aR1 expression was verified at protein level by immunohistochemistry on tumor tissue microarray. Also, high expression of JAK1 correlated with favourable overall survival (p=0.04) and high expression of IL8, derived presumably from infiltrating immune cells, resulted in poor overall survival in Ewing sarcoma (p=0.04). Conclusions: Immune system related gene activation is observed in ESFT patient samples and several prognostically significant inflammatory genes (C5, JAK1 and IL8) for ESFT were identified. 44 Ewing sarcoma family of tumor patient and 18 normal muscle samples obtained from GSE6798 and GSE3526.

Species:
human

Samples:
62

Source:
E-GEOD-17674

Updated:
Dec.12, 2014

Registered:
Sep.15, 2014


Factors: (via ArrayExpress)
Sample SAMPLE ID STATUS EFS (MONTHS) OVS (MONTHS) AGE SEX STATE TISSUE DIAGNOSIS
GSM440999 R194 dead 11.7 15.6 32 F Primary tumor Ewing
GSM441000 R196 dead 14 20.7 5 M Primary tumor Ewing
GSM44100 R29 dead 4.6 4.6 21 M Primary tumor Ewing
GSM441002 R30 NED 28.6 48.9 26 F Primary tumor Ewing
GSM441003 R33 dead 16.6 16.6 15 M Primary tumor Ewing
GSM441004 R34 AWD 19.4 56.5 18 M Primary tumor Ewing
GSM441005 R35 dead 10 13.6 16 F Primary tumor Ewing
GSM441006 R37 dead 9.8 9.8 11 M Primary tumor Ewing
GSM441007 R38 dead 11.3 11.3 23 M Primary tumor Ewing
GSM441008 R39 dead 47 47 16 F Primary tumor Ewing
GSM441009 R40 NED 18.2 117.3 24 M Primary tumor Ewing
GSM441010 R41 NED 125.1 125.1 15 M Primary tumor Ewing
GSM4410 R42 NED 192.2 192.2 18 M Primary tumor Ewing
GSM441012 R43 dead 24.8 35.7 17 F Recurrence tumor Ewing
GSM441013 R44 dead 19.8 25.6 30 F Recurrence tumor Ewing
GSM441014 R45 dead 17.9 24.6 15 M Recurrence not specified Askin
GSM441015 R46 dead 22.1 64.2 7 F Primary not specified PNET
GSM441016 R48 dead 31.6 46.2 17 M Metastasis tumor Ewing
GSM441017 R49 NED 18.6 126.2 34 M Metastasis tumor Ewing
GSM441018 R50 dead 58.3 99.3 16 M Metastasis not specified PNET
GSM441019 R51 dead 4.6 10.9 24 M Primary not specified Askin
GSM441020 R52 dead 14.4 23.2 22 F Recurrence tumor Ewing
GSM44102 R53 NED 87.7 87.7 19 F Primary tumor Ewing
GSM441022 R54 dead 25.9 61.5 22 M Recurrence tumor Ewing
GSM441023 R55 dead 6.8 8.5 16 F Metastasis not specified PNET
GSM441024 R57 dead 2 8.7 11 M Primary tumor Ewing
GSM441025 R58 dead 13.4 13.4 22 M Primary tumor Ewing
GSM441026 R60 NED 121.5 121.5 12 M Primary tumor Ewing
GSM441027 R61 NED 16.2 16.2 15 M Primary tumor Ewing
GSM441028 R62 NED 117.6 117.6 16 M Primary tumor Ewing
GSM441029 R63 NED 43.4 43.4 13 M Primary tumor Ewing
GSM441030 R64 dead 15.3 21.3 25 M Primary tumor Ewing
GSM44103 R65 dead 11 11 20 F Primary tumor Ewing
GSM441032 R67 dead 16.7 29.4 14 M Primary tumor Ewing
GSM441033 R69 NED 62.6 62.6 9 F Primary tumor Ewing
GSM441034 R72 NED 31.5 117.7 32 F Primary not specified PNET
GSM441035 R74 NED 110.4 110.4 27 M Primary not specified PNET
GSM441036 R75 dead 9.8 25.4 14 M Primary not specified PNET
GSM441037 R78 NED 69.5 69.5 11 F Primary not specified PNET
GSM441038 R79 NED 127.1 127.1 21 M Primary not specified PNET
GSM441039 R80 NED 23.9 68.5 8 F Primary not specified PNET
GSM441040 R81 dead 34.4 81.4 24 M Metastasis tumor Ewing
GSM44104 R83 NED 70.1 129.1 4 F Metastasis not specified PNET
GSM441042 R84 dead 27.9 41.6 9 M Metastasis tumor Ewing
GSM441044 not specified not specified not specified not specified not specified not specified not specified skeletal muscle normal
GSM441044 not specified not specified not specified not specified not specified not specified not specified skeletal muscle normal
GSM441044 not specified not specified not specified not specified not specified not specified not specified skeletal muscle normal
GSM441044 not specified not specified not specified not specified not specified not specified not specified skeletal muscle normal
GSM441044 not specified not specified not specified not specified not specified not specified not specified skeletal muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal
GSM441049 not specified not specified not specified not specified not specified not specified not specified vastus lateralis muscle normal

Tags

  • cell
  • ewing sarcoma
  • immune system
  • line
  • macrophage
  • muscle
  • protein
  • sarcoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use